Laboratory-Based Surveillance of Neisseria meningitidis Isolates from Disease Cases in Latin American and Caribbean Countries, SIREVA II 2006-2010

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ibarz Pavón, Ana Belén ^a   Lemos, Ana Paula ^b   Gorla, Maria Cecilia ^b   Regueira, Mabel ^c   Corso, A ^d   Gagetti, P ^d   Efron, A ^d   Sorohuet, C ^d   Moscoloni, M ^d   Rojas, P R ^d   Brandileone, M C ^d   Maldonado, A ^d   Prat, S ^d   Seoane, M ^d   Araya, P ^d   Realpe, M E ^d   Sanabria, O M ^d   Duarte, C ^d   Chacon, G C ^d   Llanes, R ^d   Torano G ^d   Feliciano, O ^d   Gutierrez O ^d   Almeida, C P ^d   San Martin Y N ^d   Choez J S ^d   de Fuentes, Z J ^d   Castillo, R E ^d   Terrazas, M V ^d   Echaniz Aviles G ^d   Sandino, M J ^d   Gomez A O ^d   de Quinzada, M ^d   de Bolanos R ^d   Fernandez, M ^d   Chamorro Cortesi, G A ^d   Leon Ayala M E ^d   Kawabata, A ^d   Morales, S ^d   Sanchez J ^d   Pena M ^d   Nurse Lucas, M ^d   Francis, L ^d   Camou, T ^d   Perez Giffoni G ^d   Spadola, E ^d   Payares, D ^d   Agudelo, C I ^d   Castaneda E ^d   Gabastou, Jean Marc ^a   more..

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; PENICILLIN G; RIFAMPICIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; COMPUTER NETWORK; DISEASE SURVEILLANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFORMATION PROCESSING; LABORATORY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; SCHOOL CHILD; SEROTYPE; SOUTH AND CENTRAL AMERICA;

NEISSERIA MENINGITIDIS;

EID: 84865605677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044102     Document Type: Article

References (69)

1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM, (2001) Meningococcal disease. N Engl J Med 344: 1378-1388.
2. Aguilar-Garcia J, Olalla-Sierra J, Perea-Milla E, Rivas-Ruiz F, Martos F, et al. (2009) Analysis of the epidemiological characteristics and prognostic factors in probable or confirmed invasive meningococcal disease in a cohort of adolescents and adults during an epidemic outbreak. Rev Clin Esp 209: 221-226.
3. Deghmane AE, Parent du Chatelet I, Szatanik M, Hong E, Ruckly C, et al. (2010) Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France. J Infect Dis 202: 247-250.
4. Doyle TJ, Mejia-Echeverry A, Fiorella P, Leguen F, Livengood J, et al. (2009) Cluster of serogroup W135 meningococci, southeastern Florida, 2008-2009. Emerg Infect Dis 16: 113-115.
5. Jardine A, Truman G, Sheppeard V, Gibbons D, Thomas J, et al. (2009) A community outbreak of meningococcal serogroup B disease in western Sydney: the challenges of identification and significance. Commun Dis Intell 33: 221-224.
6. Skoczynska A, Wasko I, Kuch A, Golebiewska A, Forys M, et al. (2010) Outbreak of invasive meningococcal disease in Goleniow County, northwest Poland, March 2009. Euro Surveill 15.
7. Taylor-Robinson D, Elders K, Milton B, Thurston H, (2010) Students' attitudes to the communications employed during an outbreak of meningococcal disease in a UK school: a qualitative study. J Public Health (Oxf) 32: 32-37.
8. Weiss D, Stern EJ, Zimmerman C, Bregman B, Yeung A, et al. (2009) Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York. Clin Infect Dis 48: 894-901.
9. Harrison LH, Trotter CL, Ramsay ME, (2009) Global epidemiology of meningococcal disease. Vaccine 27Suppl 2: B51-63.
10. Lapeyssonnie L (1963) La méningite cérébrospinale en Afrique. Bull World Health Organ: 1-100.
11. Greenwood B, (1999) Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93: 341-353.
12. Stephens DS, Greenwood B, Brandtzaeg P, (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210.
13. Lopez L, Sexton K, Carter P (2011) The epidemiology of meningococcal disease in New Zealand in 2010.
14. Cano R, Larrauri A, Mateo S, Alcala B, Salcedo C, et al. (2004) Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision. Euro Surveill 9: 11-15.
15. Kafetzis DA, Stamboulidis KN, Tzanakaki G, Kourea Kremastinou J, Skevaki CL, et al. (2007) Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Clin Microbiol Infect 13: 550-552.
16. Salisbury D (2001) Introduction of a conjugate meningococcal type C vaccine programme in the UK. J Paediatr Child Health 37: S34-36; discussion 37.
17. Stefanelli P, Fazio C, Sofia T, Neri A, Mastrantonio P, (2009) Serogroup C meningococci in Italy in the era of conjugate menC vaccination. BMC Infect Dis 9: 135.
18. Harrison LH, (2010) Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis 50Suppl 2: S37-44.
19. Safadi MA, Cintra OA, (2010) Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol Res 32: 263-271.
20. Gabastou JM, Agudelo CI, Brandileone MC, Castaneda E, de Lemos AP, et al. (2008) Characterization of invasive isolates of S. pneumoniae, H. influenzae, and N. meningitidis in Latin America and the Caribbean: SIREVA II, 2000-2005. Rev Panam Salud Publica 24: 1-15.
21. Castaneda E, Agudelo CI, Regueira M, Corso A, Brandileone MC, et al. (2009) Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005. Pediatr Infect Dis J 28: e265-270.
22. Di Fabio JL, Castaneda E, Agudelo CI, De La Hoz F, Hortal M, et al. (2001) Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group, 1993 to 1999. PAHO Sireva-Vigia Study Group. Pan American Health Organization. Pediatr Infect Dis J 20: 959-967.
23. Hortal M, Ruvinsky R, Rossi A, Agudelo CI, Castaneda E, et al. (2000) Impact of Streptococcus pneumoniae on pneumonia in Latin American children. SIREVA-Vigia Group. Rev Panam Salud Publica 8: 185-195.
24. Perez Rodriguez A, Meneses FO, (1999) VA-MENGOC-BC vaccine: its impact on meningococcal disease in children 1-4 years old. Rev Cubana Med Trop 51: 189-193.
25. Rodriguez AP, Dickinson F, Baly A, Martinez R, (1999) The epidemiological impact of antimeningococcal B vaccination in Cuba. Mem Inst Oswaldo Cruz 94: 433-440.
26. Sotolongo F, Campa C, Casanueva V, Fajardo EM, Cuevas IE, et al. (2008) Cuban Meningococcal BC Vaccine: Experiences & Contributions from 20 Years of Application. MEDICC Rev 9: 16-22.
27. Ministerio da Saúde do Brasil website. Available: http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id_area=1563. Accessed 2012 Aug 3.
28. OPS (2008) Informe regional de SIREVA II, 2007: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus neumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos. Washington D.C.: OPS. 273 p.
29. OPS (2008) Informe regional de SIREVA II, 2006: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus neumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos. Washington D.C.: OPS. 273 p.
30. OPS (2009) Informe regional de SIREVA II, 2008: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus neumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos. Washington D.C.: OPS. 273 p.
31. OPS (2010) Informe regional de SIREVA II, 2009: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus neumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos. Washington D.C.: OPS. 273 p.
32. OPS (2010) Informe regional de SIREVA II, 2010: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus neumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos. Washington D.C.: OPS. 273 p.
33. Di Fabio JL, Homma A, de Quadros C, (1997) Pan American Health Organization epidemiological surveillance network for Streptococcus pneumoniae. Microb Drug Resist 3: 131-133.
34. Lovgren M, Talbot JA, Brandileone MC, Casagrande ST, Agudelo CI, et al. (2007) Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae, developed for the SIREVA project in Latin America, from 1993 to 2005. J Clin Microbiol 45: 3184-3190.
35. Popovic T, Ajello G, Facklam R (1998) Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. Centers for Disease Control and Prevention and World Health Organization. 381 p.
36. Wikler ML, Low DE, Cockerill FR, Sheehan DJ, Craig WA, et al. (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard-seventh edition. Available: http://www.clsi.org/source/orders/free/m11a7.pdf.
37. Baquero F, Martinez-Beltran J, Canton R, (1998) Criteria of the MENSURA group for the definition of the critical points of sensitivity to antibiotics. Enferm Infecc Microbiol Clin 16: 85-92.
38. OPS (2007) Informe regional de SIREVA II: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus neumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos, 2000-2005. Washington D.C.: OPS. 387 p.
39. Ines Agudelo C, Sanabria OM, Ovalle MV, (2008) Serogroup Y meningococcal disease, Colombia. Emerg Infect Dis 14: 990-991.
40. Perez Giffoni G, Garcia Gabarrot G, Alfonso A, Pujadas M, Camou T, (2012) Detection of rifampicin-resistant strains of Neisseria meningitidis in Uruguay. Rev Panam Salud Publica 30: 540-544.
41. Pan American Health Organization (1996) Impact of Uruguay's introduction of the Haemophilus influenzae type b (Hib) vaccine. EPI Newsl 18: 6.
42. Agudelo CI, Munoz N, De la Hoz F, (2000) Rapid assessment of the impact of Haemophilus influenzae vaccine serotype b in Colombia. Public Health Laboratories. Rev Panam Salud Publica 8: 181-184.
43. Diaz JM, Catalan L, Urrutia MT, Prado V, Ledermann W, et al. (2001) Trends of etiology of acute bacterial meningitis in Chilean children from 1989 to 1998. Impact of the anti-H influenzae type b vaccine. Rev Med Chil 129: 719-726.
44. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, et al. (1996) Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 15: 216-222.
45. Broome CV (1986) The carrier state: Neisseria meningitidis. J Antimicrob Chemother 18 Suppl A: 25-34.
46. Cartwright KA, Stuart JM, Jones DM, Noah ND, (1987) The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 99: 591-601.
47. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, et al. (2005) Genetic analysis of meningococci carried by children and young adults. J Infect Dis 191: 1263-1271.
48. Parodi V, Allende F, Torres E, Mucedo M, Maglione R, et al. (1998) Portadores de Neisseria meningitidis en una población de Montevideo. Revista medica uruguaya: 4.
49. Núñez N, Martinez I, Izquierdo L, Álvarez N, López O (2007) Portadores de Neisseria meningitidis y Neisseria lactamica en tres grupos de edades diferentes. VacciMonitor 16.
50. Jolley KA, Kalmusova J, Feil EJ, Gupta S, Musilek M, et al. (2000) Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol 38: 4492-4498.
51. Ibarz-Pavon AB, Maclennan J, Andrews NJ, Gray SJ, Urwin R, et al. (2011) Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis 204: 1046-1053.
52. Miller E, Salisbury D, Ramsay M, (2001) Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20Suppl 1: S58-67.
53. Weidlich L, Baethgen LF, Mayer LW, Moraes C, Klein CC, et al. (2008) High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil. J Infect 57: 324-331.
54. Barroso DE, Rebelo MC, (2007) Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil. Mem Inst Oswaldo Cruz 102: 773-775.
55. Peltola H, Kataja JM, Makela PH, (1982) Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet 2: 595-597.
56. Kuzemenska P, Kriz B, Svandova E, (1984) Meningococcal meningitis in CSR: a preepidemic situation? Zentralbl Bakteriol Mikrobiol Hyg A 257: 195-203.
57. McEllistrem MC, Kolano JA, Pass MA, Caugant DA, Mendelsohn AB, et al. (2004) Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg Infect Dis 10: 451-456.
58. Russell JE, Urwin R, Gray SJ, Fox AJ, Feavers IM, et al. (2008) Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines. Microbiology 154: 1170-1177.
59. Abad R, Agudelo CI, Brandileone MC, Chanto G, Gabastou JM, et al. (2009) Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region. J Infect 59: 104-114.
60. Cartwright K (1995) Meningococcal carriage and disease. In: Cartwright K, editor. Meningococcal disease. Chichester: John Wiley & Sons Ltd. 115-146.
61. Caugant DA, Maiden MC, (2009) Meningococcal carriage and disease-population biology and evolution. Vaccine 27Suppl 2: B64-70.
62. Sorhouet Pereira C, Regueira M, Mollerach M, (2008) PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine. J Med Microbiol 57: 338-342.
63. Ministerio de Salud de Chile website. Available: http://epi.minsal.cl/evigant/evganter.htm. Accessed 2012 Aug 3.
64. PAHO/WHO Colombia regional office website-Epidemiological bulletins. Available: http://www.col.ops-oms.org/sivigila/IndiceBoletines2003.asp. Accessed 2012 Aug 3.
65. Ministerio de Salud de Paraguay-Boletín epidemiológico. Available: http://www.vigisalud.gov.py/index.php?option=com_phocadownload&view=section&id=8&Itemid=128. Accessed 2012 Aug 3.
66. Brown EM, Fisman DN, Drews SJ, Dolman S, Rawte P, et al. (2010) Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006. Antimicrob Agents Chemother 54: 1016-1021.
67. du Plessis M, von Gottberg A, Cohen C, de Gouveia L, Klugman KP, (2008) Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J Clin Microbiol 46: 3208-3214.
68. Trotter CL, Fox AJ, Ramsay ME, Sadler F, Gray SJ, et al. (2002) Fatal outcome from meningococcal disease-an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol 51: 855-860.
69. Sacchi CT, Fukasawa LO, Goncalves MG, Salgado MM, Shutt KA, et al. (2011) Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in Sao Paulo, Brazil. PLoS One 6: e20675.